Cleared Abbreviated

K122141 - IDS-ISYS IGF-I CALIBRATION VERIFIERS

K122141 is the FDA 510(k) clearance for IDS-ISYS IGF-I CALIBRATION VERIFIERS by Immunodiagnostic Systems , Ltd.. It is a Class 1 Chemistry device (product code JJX) cleared through the Abbreviated 510(k) pathway after a 19-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2012
Decision
19d
Days
Class 1
Risk

K122141 is an FDA 510(k) clearance for the IDS-ISYS IGF-I CALIBRATION VERIFIERS. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Immunodiagnostic Systems , Ltd. (Boldon, Tyne & Wear, GB). The FDA issued a Cleared decision on August 7, 2012 after a review of 19 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Immunodiagnostic Systems , Ltd. devices

Submission Details

510(k) Number K122141 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 2012
Decision Date August 07, 2012
Days to Decision 19 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 88d · This submission: 19d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 371
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K122141.
LIQUIDCHEK DIABETES CONTROL
K123798 · Bio-Rad Laboratories · Jan 2013
ELECSYS CA 15-3 II CALCHECK 5
K122242 · Roche Diagnostics · Dec 2012
ELECSYS HSV-2 IGG IMMUNOASSAY
K121895 · Roche Diagnostics · Aug 2012
RANDOX MICROALBUMIN CONTROL LEVEL 1 AND CONTROL LEVEL 2 (LIQUID)
K121746 · Randox Laboratories, Ltd. · Jul 2012
RANDOX CYSTATIN C CONTROL LEVEL 2 RANDOX CYSTATIN C CONTROL LEVEL 3
K121588 · Randox Laboratories, Ltd. · Jun 2012
BETA HCG CONTROL LEVEL 1 BETA HCG CONTROL LEVEL 2 BETA HCG CONTROL LEVEL 3 BETA HCG CALIBRATION VERIFICATION CONTROLS LE
K121237 · Cliniqa Corporation · May 2012